Rep. Lance Yednock

Filed: 3/25/2022

 

 


 

 


 
10200SB1693ham002LRB102 10886 HLH 37971 a

1
AMENDMENT TO SENATE BILL 1693

2    AMENDMENT NO. ______. Amend Senate Bill 1693 by replacing
3everything after the enacting clause with the following:
 
4
"Article 1. Industrial Biotech Partnership Act

 
5    Section 1-1. Short title. This Act may be cited as the
6Industrial Biotech Partnership Act.
 
7    Section 1-5. Purpose. Illinois will actively pursue
8expansion of the industrial biotechnology and biorenewables
9industry. This growing field closely aligns with several key
10industries that the State is pursuing through the 2019 "Plan
11to Revitalize the Illinois Economy and Build the Workforce of
12the Future", such as agriculture, agriculture technology, life
13sciences, healthcare, and manufacturing. Illinois is well
14positioned to lead the nation with ample feedstocks, dedicated
15research facilities, specialized job training programs, and an

 

 

10200SB1693ham002- 2 -LRB102 10886 HLH 37971 a

1existing manufacturing base required to lead this industry.
2Modifications to several existing programs will ensure the
3State provides the correct aid and incentives to help attract
4this growing industry.
 
5    Section 1-10. Definitions. As used in this Act:
6    "Department" means the Department of Commerce and Economic
7Opportunity.
8    "Industrial biotechnology" means biotechnology focused on
9new industrial products, such as industrial materials,
10chemicals and solvents, and feed and food, and new industrial
11processes. "Industrial biotechnology" does not include health
12biotechnology (pharmaceuticals), agricultural biotechnology
13(transgenic crops), or environmental biotechnology
14(bioremediation).
15    "Partnership" means the Industrial Biotechnology
16Public-Private Partnership established under this Act.
 
17    Section 1-15. Industrial Biotechnology Public-Private
18Partnership.
19    (a) There is hereby established the Industrial
20Biotechnology Public-Private Partnership as a State-sponsored
21board consisting of members from State agencies, research
22facilities, industry, and agriculture, to promote and market
23Illinois as the leading destination for research, development,
24and commercialization for industrial biotechnology.

 

 

10200SB1693ham002- 3 -LRB102 10886 HLH 37971 a

1    (b) The Partnership shall consist of the following
2members:
3        (1) a representative of the Department of Agriculture,
4    appointed by the Director of Agriculture;
5        (2) a representative of the Department of Commerce and
6    Economic Opportunity, appointed by the Director of
7    Commerce and Economic Opportunity;
8        (3) a representative of the Department of Labor,
9    appointed by the Director of Labor;
10        (4) a representative of the National Corn to Ethanol
11    Research Center, appointed by the Director of Commerce and
12    Economic Opportunity;
13        (5) a representative of the Integrated Bioprocessing
14    Research Laboratory, appointed by the Director of Commerce
15    and Economic Opportunity;
16        (6) a representative of the National Center for
17    Agricultural Utilization Research, who shall participate
18    in a non-voting capacity, appointed by the Director of
19    Commerce and Economic Opportunity in consultation with the
20    Director of the Agricultural Research Service of the
21    United States Department of Agriculture;
22        (7) a representative of an additional State-sponsored,
23    university-affiliated laboratory or research institution
24    conducting industrial biotechnology research, other than
25    the entities described in paragraphs (4) and (5),
26    appointed by the Director of Commerce and Economic

 

 

10200SB1693ham002- 4 -LRB102 10886 HLH 37971 a

1    Opportunity;
2        (8) a representative of an Illinois agricultural
3    commodity group or farmer organization, appointed by the
4    Director of Commerce and Economic Opportunity;
5        (9) a representative of a grain or oilseed processing
6    company with current facilities located in Illinois,
7    appointed by the Director of Commerce and Economic
8    Opportunity;
9        (10) a representative of a biotechnology company,
10    appointed by the Director of Commerce and Economic
11    Opportunity;
12        (11) a representative of an environmental group
13    committed to biorenewables, appointed by the Director of
14    Commerce and Economic Opportunity; and
15        (12) a representative of a union of operating
16    engineers, appointed by the Director of Commerce and
17    Economic Opportunity.
18    (c) Members of the Partnership shall be appointed within
1990 days after the effective date of this Act. The Partnership
20may meet quarterly and may hold its first meeting within 90
21days after the appointment of all members. At the first
22meeting of the Partnership, a Chairperson shall be chosen from
23among the members. Members of the Partnership shall serve
24without compensation, but may be reimbursed for any expenses
25incurred in performing their duties.
26    (d) The Department, or a non-profit organization

 

 

10200SB1693ham002- 5 -LRB102 10886 HLH 37971 a

1designated by the Department, shall provide administrative and
2other support to the Partnership.
 
3    Section 1-20. Duties. The Partnership shall have the
4following duties:
5        (1) Subject to appropriation and matching private
6    funds as provided in Section 1-25, the Partnership shall
7    develop and direct efforts to attract companies to use
8    existing Illinois facilities for research, development,
9    and pre-commercialization activities. Those efforts may
10    include, without limitation: (i) representing Illinois at
11    biotechnology conferences; (ii) developing promotional and
12    marketing materials in coordination with existing research
13    facilities to encourage the use of Illinois facilities;
14    and (iii) facilitating meetings for companies that are
15    prospective candidates for establishing a presence in this
16    State.
17        (2) Subject to appropriation and matching private
18    funds as provided in Section 1-25, the Partnership may
19    develop programs to encourage emerging research,
20    development, and commercializing biotechnology companies
21    to locate production facilities in Illinois, including,
22    but not limited to: (i) acting as an information
23    clearinghouse for new companies on all State programs and
24    investment incentives; and (ii) working with local and
25    regional economic development groups.

 

 

10200SB1693ham002- 6 -LRB102 10886 HLH 37971 a

1        (3) The Partnership may provide advice and
2    recommendations to State agencies on the administration of
3    grant programs directed at industrial biotechnology.
4        (4) On or before January 31 of the next calendar year
5    to occur after the last day of any State fiscal year in
6    which the Partnership receives State funding, the
7    Partnership shall submit a report to the Department
8    describing the use of appropriated funds by the
9    Partnership in the State fiscal year for which the funds
10    were allocated. The report shall include, but not be
11    limited to, marketing materials produced by the
12    Partnership, meetings attended by members of the
13    Partnership related to Partnership business, and the
14    hosting of companies visiting this State.
 
15    Section 1-25. Funding. The Partnership may receive funding
16through specific appropriations available for its purposes
17made to the Department. Moneys appropriated to the Department
18for the use of the Partnership as provided in this Act shall
19not be disbursed to the Partnership until the Partnership
20certifies to the Department that it has received at least $3 in
21private matching funds for every $1 so disbursed.
 
22    Section 1-30. Reports. On or before January 31 of the next
23calendar year to occur after the last day of any State fiscal
24year in which the Partnership receives State funding, the

 

 

10200SB1693ham002- 7 -LRB102 10886 HLH 37971 a

1Department shall submit to the General Assembly and the
2Governor a report describing the use of appropriated funds by
3the Partnership in the State fiscal year for which the funds
4were allocated.
 
5    Section 1-35. Rules. The Department shall adopt all rules
6necessary for the implementation of this Act.
 
7    Section 1-40. Partnership dissolved. The Partnership is
8dissolved on December 31, 2025.
 
9    Section 1-45. Repeal. This Act is repealed on January 1,
102027.
 
11
Article 90. Amendatory Provisions

 
12    Section 90-5. The Department of Commerce and Economic
13Opportunity Law of the Civil Administrative Code of Illinois
14is amended by adding Section 605-1095 as follows:
 
15    (20 ILCS 605/605-1095 new)
16    Sec. 605-1095. Industrial Biotechnology Workforce
17Development Grant Program.
18    (a) The Industrial Biotechnology Workforce Development
19Grant Program is hereby established as a program to be
20implemented and administered by the Department. The Program

 

 

10200SB1693ham002- 8 -LRB102 10886 HLH 37971 a

1shall provide grants for the purpose of fostering a
2well-trained and well-skilled industrial biotechnology
3workforce.
4    (b) Subject to appropriation, grants under the Program may
5be awarded on an annual basis for one or more of the following:
6        (1) industrial biotechnology apprenticeships or
7    apprenticeship programs;
8        (2) industrial biotechnology talent pipeline
9    management programs that emphasize business-oriented
10    strategies to increase workforce competitiveness, improve
11    workforce diversity, and expand a regional talent pool
12    around high-growth industries;
13        (3) industrial biotechnology industry-aligned
14    credential (digital badging) expansion programs to
15    increase the number of workers with in-demand skills
16    needed to obtain a job or advance within the workplace and
17    for merging competency-based education with responsive
18    workforce training strategies; and
19        (4) high school and community college industrial
20    biotechnology career pathway and pre-apprenticeship
21    program development.
22    (c) To be eligible for grants provided under the Program,
23an entity must be either: (i) a State-sponsored,
24university-affiliated laboratory or research institution
25conducting collaboratives or for-hire research in the
26development of biorenewable chemicals, bio-based polymers,

 

 

10200SB1693ham002- 9 -LRB102 10886 HLH 37971 a

1materials, novel feeds, or additional value-added
2biorenewables; or (ii) a State-accredited university or
3community college. An eligible entity must establish that it
4plans to use grant funds for a purpose specifically provided
5under subsection (b).
6    (d) On or before January 31 of the next calendar year to
7occur after the last day of any State fiscal year in which the
8Department of Commerce and Economic Opportunity receives State
9funding for the Program under this Section, the Department of
10Commerce and Economic Opportunity shall submit an annual
11report to the General Assembly and the Governor on the use of
12grant funds under the Program. The report shall include, but
13not be limited to: (i) the disbursement of grant funds,
14categorized by eligible entity; (ii) the number of persons
15enrolled in or taking advantage of a program established or
16maintained using grant funds; (iii) the number of persons
17completing a program established or maintained using grant
18funds; and (iv) the number of person gaining employment in the
19industrial biotechnology industry following completion of a
20program established or maintained using grant funds.
21    (e) The Department shall adopt all rules necessary for the
22implementation and administration of the Program under this
23Section.
 
24    Section 90-10. The State Finance Act is amended by adding
25Sections 6z-130 and 6z-131 as follows:
 

 

 

10200SB1693ham002- 10 -LRB102 10886 HLH 37971 a

1    (30 ILCS 105/6z-130 new)
2    Sec. 6z-130. Industrial Biotechnology Human Capital Fund.
3    (a) The Industrial Biotechnology Human Capital Fund is
4created as a special fund in the State treasury and may receive
5funds from any source, public or private, including moneys
6appropriated for use by the Department of Commerce and
7Economic Opportunity and laboratories and institutions
8conducting industrial biotechnology research. Subject to
9appropriation, the Industrial Biotechnology Human Capital Fund
10shall receive moneys from the General Revenue Fund until June
1130, 2025. Each eligible entity receiving a grant under this
12Section shall, as a condition of receiving the grant,
13contribute moneys to the Fund as part of a cost-sharing
14agreement between the grantee and the Department of Commerce
15and Economic Opportunity in accordance with rules adopted by
16the Department of Commerce and Economic Opportunity. Grants
17issued under the Section may be for a period of 2 years. An
18eligible entity issued a grant under this Sections shall be
19eligible for more than one such grant, but no more than one
20grant annually, for the purpose of hiring and retaining
21Experts in Residence; however, such entity may maintain more
22than one grant at any given time.
23    (b) Subject to appropriation, moneys in the Fund shall be
24used for providing grants to laboratories and research
25institutions for the purpose of hiring and retaining in-house

 

 

10200SB1693ham002- 11 -LRB102 10886 HLH 37971 a

1specialists, to be known as experts in residence, with the
2knowledge and experience in moving industrial biotechnology
3products through the development phase.
4    (c) To be eligible for grants provided from the Fund, an
5entity must be a State-sponsored, university-affiliated
6laboratory or research institution conducting collaboratives
7or for-hire research in the development of biorenewable
8chemicals, bio-based polymers, materials, novel feeds, or
9additional value added biorenewables. Eligible entities must
10also establish that the Expert-In-Residence they seek to hire
11or retain using the grant funds possesses expertise in
12fermentation engineering, process engineering, catalytic
13engineering, analytical chemistry, or is a scale-up
14specialist.
15    (d) On or before January 31 of the next calendar year to
16occur after the last day of any State fiscal year in which the
17Department of Commerce and Economic Opportunity receives State
18funding for the Program under this Section, the Department of
19Commerce and Economic Opportunity shall submit an annual
20report to the General Assembly and the Governor on the use of
21moneys in the Fund. The report shall include, but not be
22limited to: (i) the number of laboratories or institutions
23utilizing moneys in the Fund, including the name of such
24entities; (ii) the number of experts in residence hired by
25each laboratory or institution; (iii) the expertise or
26specialty area of each expert in residence hired or retained;

 

 

10200SB1693ham002- 12 -LRB102 10886 HLH 37971 a

1and (iv) a summary of the benefit to the economy of the State
2of Illinois economy in providing the grants.
3    (e) The Department of Commerce and Economic Opportunity
4shall adopt all rules necessary for the implementation of this
5Section.
 
6    (30 ILCS 105/6z-131 new)
7    Sec. 6z-131. Industrial Biotechnology Capital Maintenance
8Fund.
9    (a) The Industrial Biotechnology Capital Maintenance Fund
10is created as a special fund in the State treasury and may
11receive funds from any source, public or private, including
12from moneys appropriated for use by the Department of Commerce
13and Economic Opportunity and laboratories and institutions
14conducting industrial biotechnology research.
15    (b) Subject to appropriation, moneys in the Fund shall be
16used for providing grants to laboratories and research
17institutions for the purpose of maintenance and repair of
18capital assets. Such maintenance and repairs of capital assets
19shall be designed to extend the serviceable life of equipment
20and buildings and expand the capacity of equipment and
21buildings by at least 10%. For the purposes of this Section,
22"capital assets" means equipment or buildings that have a
23value greater than $250,000.
24    (c) To be eligible for grants provided from the Fund, an
25entity must be a State-sponsored, university-affiliated

 

 

10200SB1693ham002- 13 -LRB102 10886 HLH 37971 a

1laboratory or research institution conducting collaboratives
2or for-hire research in the development of biorenewable
3chemicals, bio-based polymers, materials, novel feeds, or
4additional value added biorenewables. The Department of
5Commerce and Economic Opportunity shall determine the
6disbursement of moneys for the purposes of this Section. Each
7eligible entity, as a condition of receiving a grant under
8this Section, shall match up to at least 50% of the moneys to
9be granted to the entity.
10    (d) On or before January 31 of the next calendar year to
11occur after the last day of any State fiscal year in which the
12Department of Commerce and Economic Opportunity receives State
13funding for the Program under this Section, the Department of
14Commerce and Economic Opportunity shall submit an annual
15report to the General Assembly and the Governor on the use of
16moneys in the Fund. The report shall include, but not be
17limited to: (i) the name of the institution or laboratory
18receiving funds; (ii) the capital assets that were maintained
19or repaired at each institution or laboratory; (iii) the
20expected usable life extension of each maintained or repaired
21asset; and (iv) the capacity increase of each maintained or
22repaired asset.
23    (e) The Department of Commerce and Economic Opportunity
24shall adopt all rules necessary for the implementation of this
25Section.".